PAR
Click for more information
0.00% 19.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4286

  1. Beaza79
    5,196 Posts.
    lightbulb Created with Sketch. 671
    clock Created with Sketch.
    21/07/24
    15:07
    Post #: 74846601
    I assume this is after phase 2. If they are bought out during phase 3 trials they wouldn’t be classified as phase 2
    PAR Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS New gold-copper assays boost confidence in major porphyry target—discover the potential
right-arrow Created with Sketch.
EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
NEWS Exceptional rock chip assays at Pearl Copper Project—up to 930 g/t Ag and 10.05% Cu in Arizona
right-arrow Created with Sketch.
NEWS High-grade copper-gold at Mt Isa North—grab samples hit up to 30% Cu and more, with drilling set to begin
right-arrow Created with Sketch.
NEWS Shallow high-grade gold hits at Star of Mangaroon and Popeye—see the latest drill results and what’s next
right-arrow Created with Sketch.
NEWS High-grade drilling results extend Cowboy State Mine—172.4m @ 3,716 ppm TREO confirmed
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $69.17M
Open High Low Value Volume
19.5¢ 20.5¢ 19.0¢ $148.3K 754.7K

Buyers (Bids)

No. Vol. Price($)
8 115443 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 7123 5
View Market Depth
Last trade - 14.49pm 01/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.